Literature DB >> 27305139

Rivaroxaban twice daily for lysis of left atrial appendage thrombus: a potential new therapeutic option.

Roman Piotrowski, Beata Zaborska, Jakub Baran, Małgorzata Sikora-Frąc, Piotr Kułakowski.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27305139     DOI: 10.20452/pamw.3435

Source DB:  PubMed          Journal:  Pol Arch Med Wewn


× No keyword cloud information.
  5 in total

Review 1.  Non-vitamin K antagonist oral anticoagulants for the treatment of intracardiac thrombosis.

Authors:  Eiman Ghaffarpasand; Maneli D Tehrani; Jolanta Marszalek; Gerald Chi
Journal:  J Thromb Thrombolysis       Date:  2018-10       Impact factor: 2.300

2.  Are Three Weeks of Oral Anticoagulation Sufficient for Safe Cardioversion in Atrial Fibrillation?

Authors:  Stefan Naydenov; Nikolay Runev; Emil Manov
Journal:  Medicina (Kaunas)       Date:  2021-05-31       Impact factor: 2.430

3.  RIVAroxaban TWICE daily for lysis of thrombus in the left atrial appendage in patients with non-valvular atrial fibrillation: the RIVA-TWICE study.

Authors:  Roman Piotrowski; Beata Zaborska; Ewa Pilichowska-Paszkiet; Małgorzata Sikora-Frąc; Jakub Baran; Piotr Kułakowski
Journal:  Arch Med Sci       Date:  2019-07-12       Impact factor: 3.318

4.  Prevalence and Rate of Resolution of Left Atrial Thrombus in Patients with Non-Valvular Atrial Fibrillation: A Two-Center Retrospective Real-World Study.

Authors:  Pompilio Faggiano; Elisabetta Dinatolo; Antonella Moreo; Benedetta De Chiara; Marco Sbolli; Francesco Musca; Antonio Curnis; Oriana Belli; Cristina Giannattasio; Cesare Tomasi; Marco Metra; Gloria Santangelo
Journal:  J Clin Med       Date:  2022-03-10       Impact factor: 4.241

Review 5.  Resolution of massive left atrial appendage thrombi with rivaroxaban before balloon mitral commissurotomy in severe mitral stenosis: A case report and literature review.

Authors:  Yuechun Li; Jiafeng Lin; Chen Peng
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.